PEG as a safe alternative after BDDE-related delayed inflammatory reaction: a case report

REPORT summary

Patient

A patient with prior delayed inflammatory reaction to BDDE-based fillers requested HA treatment three years after resolution.

Results

A total of 2 ml was injected bilaterally into the lateral and mid-to-lower face using linear retrograde and fanning techniques. At 12-month follow-up, volume and skin quality were restored with no inflammatory recurrence.

Treatments

Neauvia Stimulate (PEG-crosslinked HA 26 mg/ml + 1% CaHA) was chosen for safety and dual volumizing/biostimulatory action.

Dr. Cosmina Sandor
Dermatologist
Romania

want to know more about
our treatments?

 

Lorem ipsum dolor sit amet consectetur. Elementum feugiat risus morbi et nulla aliquam tortor adipiscing. Erat quam neque morbi ornare leo duis viverra massa est.

    Response channel: